GMP training for dietary supplement manufacturers, contract manufacturers, and own-label distributors — built around 21 CFR Part 111: identity testing, master manufacturing records, batch production records, quality control operations, and complaint files. Taught by a practicing GMP consultant, on-site or live online, with the training records Part 111 requires you to keep.
21 CFR 111.12 requires qualified personnel; 111.14 requires the records that prove it. We deliver both the training and the documentation.
Course material drawn from real supplement-industry audits, real 483 observations, and real remediations — not hypotheticals.
Tracks for contract manufacturers on the floor and own-label distributors who carry Part 111 responsibility without a facility.
Workshops at your facility, live virtual instructor-led sessions, or custom annual training programs built around your quality system.
Dietary supplement GMP is not a lighter version of drug GMP — it is its own regulation, 21 CFR Part 111, with its own logic and its own personnel requirements. 21 CFR 111.12(c) says it plainly: each person engaged in manufacturing, packaging, labeling, or holding a dietary supplement — or performing any quality control operation — "must have the education, training, or experience to perform the person's assigned functions." Supervisors carry the same qualification requirement under 111.12(d), and 21 CFR 111.14 requires you to make and keep the records documenting that training: who was trained, in what, and when.
In an FDA inspection, those two sections work together as a trap for the unprepared. The investigator asks for your training records (111.14), then walks the floor and asks operators questions their records say they were trained to answer (111.12). If the blender operator cannot explain the in-process checks on the batch record they signed, the training record proves the opposite of what it was supposed to prove. Training deficiencies also surface indirectly — through failures in identity testing, batch record completion, and quality control review that trace back to people who never understood the requirement.
The supplement industry has a further complication: much of it runs on contract manufacturing. FDA's position, expressed consistently in warning letters, is that responsibility follows the product, not the purchase order. Contract manufacturers are directly subject to Part 111 for the operations they perform — and own-label distributors who market supplements under their brand remain responsible for those products, including establishing specifications and reviewing manufacturing records. "Our co-packer handles GMP" is not a defense FDA accepts. Both sides of that relationship need people trained in what Part 111 actually requires of them.
Programs are assembled from these core modules and scoped to your operation — powder blending, encapsulation, gummies, liquids, or brand-owner oversight of a contract manufacturer.
The 111.75(a)(1) requirement to identity test 100% of incoming dietary ingredient lots — appropriate test selection, scientifically valid methods, why a supplier's certificate of analysis alone doesn't satisfy it, and the petition process for testing less than 100%.
Building MMRs that satisfy 111.205–210: one for each unique formulation and batch size, complete specifications, weight/measure controls for each ingredient, and written instructions precise enough that the batch cannot drift from the design.
Executing BPRs under 111.255–260: documenting each step at the time of performance, good documentation practices, in-process checks, deviation capture, and the quality-unit review that must happen before release.
Subpart F's quality control duties: approving or rejecting components, in-process specifications, finished batches, and label operations; conducting material reviews; and making disposition decisions the regulation reserves for quality control personnel.
Subpart J requirements: adequate lab facilities, scientifically valid test methods, criteria for using in-house versus contract laboratories, and keeping the testing records that support every specification decision.
Subpart M: holding components, dietary supplements, packaging, and labels under conditions that protect identity, purity, strength, and composition — plus distribution records that enable trace-back when something goes wrong.
Subpart O: what counts as a product complaint, quality-personnel review, when a complaint triggers an investigation into the batch (and related batches), and the connection to serious adverse event reporting obligations.
The orientation module: how Part 111 is organized, the 111.12/111.14 personnel and training-record requirements, hygiene and sanitation basics, and each role's place in the quality system. The right starting point for new hires.
Also manufacture drug products or need broader documentation and CAPA coverage? See pharmaceutical GMP training and the full cGMP course catalog.
Part 111 responsibility reaches everyone who touches the product — and, in the supplement industry, plenty of people who never do. Each audience gets content matched to its actual obligations.
Blender operators, encapsulation and tableting staff, packaging lines, and warehouse personnel: executing batch records correctly, in-process checks, sanitation, material handling and status controls, and recognizing when something on the line needs to be escalated rather than worked around.
The people Part 111 leans on hardest: quality control's approval and rejection duties, material review and disposition decisions, specification setting, identity testing programs, lab operations, and the batch record review that stands between production and release.
Facilities making other brands' products are directly subject to Part 111 for every operation they perform. Training covers the full manufacturing scope — plus the customer-facing realities: audits by brand owners, shared specification responsibilities, and documentation your customers' regulators will read.
If your name is on the bottle, FDA holds you responsible for the product — even with no facility of your own. Training covers what you must establish and verify: specifications, qualification of your contract manufacturer, record review, complaint files, and what to ask for before you release a lot for sale.
Part 111 requires qualified personnel and documented training — it does not set a calendar. That flexibility is a test: FDA expects your written procedures to define the training program, and your records to prove you followed it. The widely adopted industry practice is an annual GMP refresher for all personnel, supplemented by event-driven training whenever procedures change, deviations reveal a gap, or new products and equipment arrive on the floor.
A refresher that re-runs last year's slides trains no one. Ours are rebuilt around what actually happened: your deviation and complaint trends from the past year, procedure changes, and current FDA enforcement themes in the supplement industry. Custom annual programs schedule the cycle in advance, so training stops being a scramble before an audit and becomes part of how the site runs. Every session produces the attendance, content, and assessment records 111.14 requires you to keep.
At your facility, using your MMRs, batch records, and SOPs as the training material. Best for onboarding production teams and preparing for an FDA inspection or customer audit.
Instructor-led over video, fully interactive, with the same documentation package. Ideal for own-label distributors and multi-site quality teams. Online training details →
Annual training plans, refresher curricula, and role-based tracks designed around your product types, your quality system, and your audit history.
When training surfaces a systems gap — a missing specification, an identity testing shortfall, an MMR that won't survive review — the same instructor can help you fix it through Certify Consulting, the consulting practice behind the Institute.
1. Scoping. We start with your operation: what you make (powders, capsules, tablets, gummies, liquids), whether you manufacture in-house, run as a contract manufacturer, or oversee a co-packer as a brand owner, your team's roles, and whatever is driving the request — an FDA inspection, a customer audit, a 483 response, or an annual training plan coming due. Recent findings and deviation trends become the spine of the curriculum, because training should target your actual failure modes.
2. Curriculum design. Modules are selected and tuned to your products and procedures. Where it strengthens the training, your own master manufacturing records, batch records, and SOPs become the exercise material — operators practice documentation on the forms they will actually sign, and quality staff review the records they will actually disposition.
3. Delivery. On-site at your facility or live over video, always instructor-led and interactive. Sessions run on scenarios — an identity test that fails, a batch record with a gap, a complaint that might be a serious adverse event — because adults learn GMP from cases, not from regulation read-alouds.
4. Documentation and follow-up. You receive the complete training record package 111.14 expects you to keep: attendance, content outline, and assessment results, ready for your files and the next investigator or customer auditor who asks. Where sessions surface systemic gaps, you get a candid summary of what we saw. Start the scoping conversation →
Jared Clark — JD, MBA, PMP, CMQ-OE, CQA, CPGP, RAC
Principal Consultant at Certify Consulting and holder of ASQ's Certified Pharmaceutical GMP Professional credential. Jared doesn't just teach GMP — he implements it, with 200+ client engagements spanning supplement, drug, cosmetics, and food manufacturing, including extensive Part 111 work with contract manufacturers and brand owners. His legal training (JD) and RAC credential supply the regulatory "why" behind every requirement your team learns.
Yes. 21 CFR 111.12(c) requires that each person engaged in manufacturing, packaging, labeling, or holding a dietary supplement — or performing any quality control operation — have the education, training, or experience to perform their assigned functions. 111.14 requires records documenting that training. Investigators ask for those records and test them against what people on the floor actually know.
Both. Contract manufacturers are directly subject to Part 111 for the operations they perform. Own-label distributors marketing supplements made by a co-packer remain responsible for the products bearing their name — including establishing specifications and reviewing manufacturing records — and FDA warning letters have repeatedly cited own-label distributors under Part 111.
Under 111.75(a)(1), you must conduct at least one appropriate test or examination to verify the identity of every incoming lot of dietary ingredient before use — hence "100% identity testing." A supplier's certificate of analysis alone does not satisfy it. Companies may petition FDA under 111.75(a)(1)(ii) for an exemption to test less than 100%, but until granted, every lot gets tested.
Part 111 doesn't prescribe a frequency — it requires qualified personnel and documented training. Most companies adopt an annual refresher plus event-driven training when procedures change, deviations reveal gaps, or new products and equipment arrive. Define the cadence in your written procedures and keep the records that prove you followed it.
Yes. The regulation requires qualification and documentation, not a classroom. Our live virtual instructor-led sessions deliver the same Part 111 curriculum and the same documentation package as on-site workshops — a good fit for own-label distributors and distributed quality teams.
Tell us your operation — manufacturer, contract manufacturer, or brand owner — your team size, and your compliance deadline. We'll design a Part 111 training program around it, and document every minute.